Update on Cardiac Tumors – review (RCD code: VI)

Monika Komar, Giovanni La Canna, Ula Gancarczyk, Prochownik Prochownik, Hanna Dziedzic-Oleksy, Piotr Podolec

Full Text:

PDF

Abstract


The prevalence of cardiac tumors is 0.021% (1 person in 5000). These data are based on a meta-analysis of pathological studies from the early decades of the twentieth century. It is likely that nowadays the incidence of cardiac tumors and primary tumors of the heart is greater. The cardiac tumors are very rare and histologically heterogeneous. These leads to, the lack of established diagnostic schemes, that would allow to distinguish cardiac tumors from metastatic tumors, intracardiac thrombus, vegetations on the valves in infective endocarditis or in the process of connective tissue diseases or thrombotic changes of the valves in the process of metastatic disease (called endocarditis marantica). Cardiac tumors may be symptomatic or found incidentally during evaluation for a seemingly unrelated problem or physical finding. In symptomatic patients, a mass can virtually always be detected by echocardiography, magnetic resonance imaging (MRI), and/or computed tomography (CT). Because symptoms may mimic other cardiac conditions, the clinical challenge is to consider the possibility of a cardiac tumor so that the appropriate diagnostic tests can be conducted. There are very few studies, assessing the results of cardiac surgery in the individual centers. There is also lack of set of standards in the chemotherapy of malignant cardiac tumors. Moreover its routine use is sometimes discussed. JRCD 2014; 1 (8): 5–10

Keywords


rare disease, malignancy, cancer, heart mass

References


Reynen K. Frequency of primary tumors of the heart. Am J Cardiol 1996; 77: 107.

Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993; 117: 1027–1031.

Tumors of the cardiovascular system. In: Atlas of Tumor Pathology, Second, Armed Forces Institute of Pathology, Washington, DC 1978. Vol Fascicle 15.

Salcedo EE, Cohen GI, White RD, Davison MB. Cardiac tumors: diagnosis and management. Curr Probl Cardiol 1992; 17: 73–137.

Primary tumors of the heart. In: Heart Disease, 6th, WB Saunders, 2001.

Kumar S, Chaudhry MA, Khan I, et al. Metastatic left atrial synovial sarcoma mimicking a myxoma. J Thorac Cardiovasc Surg 2004; 128: 756–758.

Simcha W, Wells BG, Tynan MJ. Primary cardiac tumors in childhood. Arch Dis Child 1971; 46: 508–514.

Nadas AS, Ellison RC. Cardiac tumors in infancy. J Cardiol 1968;21: 363–366.

Elbardissi AW, Dearani JA, Daly RC, et al. Embolic potential of cardiac tumors and outcome after resection: a case-control study. Stroke 2009; 40: 156–162.

de Lucas EM, Pagola MA, Fernández F, et al. CT findings and radiopathologic correlation. Cardiovasc Intervent Radiol 2004; 27: 190–191.

Lee VH, Connolly HM, Brown RD Jr. Central nervous system manifestations of cardiac myxoma. Arch Neurol 2007; 64: 1115–1120.

Engberding R, Daniel WG, Erbel R, et al. Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. European Cooperative Study Group. Eur Heart J 1993; 14: 1223–1228.

Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics 1999; 19: 1421–1434.

Constantine G, Shan K, Flamm SD, Sivananthan MU. Role of MRI in clinical cardiology. Lancet 2004; 363: 2162–2171.

Gilkeson RC, Chiles C. MR evaluation of cardiac and pericardial malignancy. Magn Reson Imaging Clin N Am 2003; 11: 173–186.

Bleiweis MS, Georgiou D, Brundage BH. Detection of intracardiac masses by ultrafast computed tomography. Am J Card Imaging 1994; 8: 63–68.

Kaminaga T, Takeshita T, Kimura I. Role of magnetic resonance imaging for evaluation of tumors in the cardiac region. Eur Radiol 2003; 13 Suppl 4: L1–10.

Hoey ET, Mankad K, Puppala S, et al. MRI and CT appearances of cardiac tumours in adults. Clin Radiol 2009; 64: 1214–1230.

García JR, Simo M, Huguet M, et al. Usefulness of 18-fluorodeoxyglucose positron emission tomography in the evaluation of tumor cardiac thrombus from renal cell carcinoma. Clin Transl Oncol 2006; 8: 124–128.

Agostini D, Babatasi G, Galateau F, et al. Detection of cardiac myxoma by F-18 FDG PET. Clin Nucl Med 1999; 24: 159–160.

Steinberg I, Miscall L, Redo SF. Angiocardiography in diagnosis of cardiac tumors. Am J Roentgenol Radium Ther Nucl Med. 1964; 91: 364–378.

Molina JE, Edwards JE, Ward HB. Primary cardiac tumors: experience at the University of Minnesota. Thorac Cardiovasc Surg 1990; 38 Suppl 2: 183–191.

Odim J, Reehal V, Laks H, et al. Surgical pathology of cardiac tumors. Two decades at an urban institution. Cardiovasc Pathol 2003; 12: 267–270.

Pucci A, Gagliardotto P, Zanini C, et al. Histopathologic and clinical characterization of cardiac myxoma: review of 53 cases from a single institution. Am Heart J 2000; 140: 134–138.

Kono T, Koide N, Hama Y, et al. Expression of vascular endothelial growth factor and angiogenesis in cardiac myxoma: a study of fifteen patients. J Thorac Cardiovasc Surg 2000; 119: 101–107.

Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80: 159–172.

Keeling IM, Oberwalder P, Anelli-Monti M, et al. Cardiac myxomas: 24 years of experience in 49 patients. Eur J Cardiothorac Surg 2002; 22: 971–977.

Jelic J, Milicić D, Alfirević I, et al. Cardiac myxoma: diagnostic approach, surgical treatment and follow-up. A twenty years experience. J Cardiovasc Surg (Torino) 1996; 37: 113–117.

Maisch B. Immunology of cardiac tumors. Thorac Cardiovasc Surg 1990; 38 Suppl 2: 157–163.

Seino Y, Ikeda U, Shimada K. Increased expression of interleukin 6 mRNA in cardiac myxomas. Br Heart J 1993; 69: 565–567.

Selkane C, Amahzoune B, Chavanis N, et al. Changing management of cardiac myxoma based on a series of 40 cases with long-term follow-up. Ann Thorac Surg 2003; 76: 1935–1938.

Centofanti P, Di Rosa E, Deorsola L, et al. Primary cardiac tumors: early and late results of surgical treatment in 91 patients. Ann Thorac Surg 1999; 68: 1236–1241.

Bakaeen FG, Reardon MJ, Coselli JS, et al. Surgical outcome in 85 patients with primary cardiac tumors. Am J Surg 2003; 186: 641–651.

Bhan A, Mehrotra R, Choudhary SK, et al. Surgical experience with intracardiac myxomas: long-term follow-up. Ann Thorac Surg 1998; 66: 810–813.

Vidaillet HJ Jr, Seward JB, Fyke FE 3rd, et al. “Syndrome myxoma”: a subset of patients with cardiac myxoma associated with pigmented skin lesions and peripheral and endocrine neoplasms. Br Heart J 1987; 57: 247–255.

Alrashdi I, Bano G, Maher ER, Hodgson SV. Carney triad versus Carney Stratakis syndrome: two cases which illustrate the difficulty in distinguishing between these conditions in individual patients. Fam Cancer 2010; 9: 443–447.

Burke AP, Cowan D, Virmani R. Primary sarcomas of the heart. Cancer 1992; 69: 387–395.

Lisy M, Beierlein W, Müller H, et al. Left atrial epithelioid hemangioendothelioma. J Thorac Cardiovasc Surg 2007; 133: 803–804.

Castorino F, Masiello P, Quattrocchi E, Di Benedetto G. Primary cardiac rhabdomyosarcoma of the left atrium: an unusual presentation. Tex Heart Inst J 2000; 27: 206–208.

Pins MR, Ferrell MA, Madsen JC, et al. Epithelioid and spindle-celled leiomyosarcoma of the heart. Report of 2 cases and review of the literature. Arch Pathol Lab Med 1999; 123: 782–788.

Kosuga T, Fukunaga S, Kawara T, et al. Surgery for primary cardiac tumors. Clinical experience and surgical results in 60 patients. J Cardiovasc Surg (Torino) 2002; 43: 581–587.

Bakaeen FG, Jaroszewski DE, Rice DC, et al. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era. J Thorac Cardiovasc Surg 2009; 137: 1454–1460.

Simpson L, Kumar SK, Okuno SH, et al. Malignant primary cardiac tumors: review of a single institution experience. Cancer 2008; 112: 2440–2446.

Gowdamarajan A, Michler RE. Therapy for primary cardiac tumors: is there a role for heart transplantation? Curr Opin Cardiol 2000; 15: 121–125.

Grandmougin D, Fayad G, Decoene C, et al. Total orthotopic heart transplantation for primary cardiac rhabdomyosarcoma: factors influencing long-term survival. Ann Thorac Surg 2001; 71: 1438–1441.

Reardon MJ, Malaisrie SC, Walkes JC, et al. Cardiac autotransplantation for primary cardiac tumors. Ann Thorac Surg 2006; 82: 645–650.

Ikeda H, Nakamura S, Nishimaki H, et al. Primary lymphoma of the heart: case report and literature review. Pathol Int 2004; 54: 187–195.

Lupinski RW, Shankar S, Agasthian T, et al. Primary cardiac paraganglioma. Ann Thorac Surg 2004; 78: e43–44.

Fernandez LA, Couban S, Sy R, Miller R. An unusual presentation of extramedullary plasmacytoma occurring sequentially in the testis, subcutaneous tissue, and heart. Am J Hematol 2001; 67: 194–196.

Longo R, Mocini D, Santini M, et al. Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. J Clin Oncol 2004; 22: 5012–5014.

Sosinska-Mielcarek K, Sosvinska-Mielcarek K, Senkus-Konefka E, et al. Cardiac involvement at presentation of non-small-cell lung cancer. J Clin Oncol 2008; 26: 1010–1011.

Labib SB, Schick EC Jr, Isner JM. Obstruction of right ventricular outflow tract caused by intracavitary metastatic disease: analysis of 14 cases. J Am Coll Cardiol 1992; 19: 1664–1668.




DOI: http://dx.doi.org/10.20418%2Fjrcd.vol1no8.158

Refbacks

  • There are currently no refbacks.
Journal of Rare Cardiovascular Diseases (JRCD)
John Paul II Hospital in Kraków, 80 Prądnicka Str., 31-202 Kraków, Poland
Phone: +48 (12) 614 33 99, +48 (12) 614 34 88 Fax: +48 (12) 614 34 88
e-mail: rarediseases@szpitaljp2.krakow.pl
Published by SoftQ sp. z o.o.
ul. Oleandry 2, 30-063 Kraków, Poland
Phone: +48 (12) 444 1650 Fax: +48 (12) 444 1659
e-mail: softq@softq.pl